Indeed, mutant p53 (mutp53) in heterozygosity loses the ability to transactivate its target genes and exerts a dominant trans-repressive effect on its wild-type counterpart, sustaining cell proliferation, cell migration, metastasis and chemoresistance that transform it from the guardian of the genome into the guardian of cancer cells [62]. This evidence concerns the gene TP53 and cancer.